Dana J Holger

11PUBLICATIONS
30CO-AUTHORS
Medical bacteriologyInfant and child healthMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 15, 2026
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.

|Apr 22, 2026
Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections.

|Dec 05, 2025
Impact of Pseudomonas aeruginosa biofilm exopolysaccharide composition on bacteriophage and bacteriophage-antibiotic combination activity.

Sean R Van Helden, Callan R Bleick, Dana J Holger

|Jan 25, 2024
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM.

Dana J Holger, Ali Althubyani, Taylor Morrisette

|Oct 25, 2023
Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models.

Amer El Ghali, Kyle Stamper, Ashlan J Kunz Coyne

|Oct 19, 2023
Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models.

Dana J Holger, Amer El Ghali, Natasha Bhutani

Pageof 2

Frequent Collaborators

8 joint publications

Michael J Rybak

6 joint publications

Ashlan J Kunz Coyne

4 joint publications

Amer El Ghali

3 joint publications

Nicholas Rebold